Cardioprotection on Chemotherapy-Induced Cardiotoxicity
ConditionCardiotoxicity
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age1-18
SponsorAin Shams University
About this trial
The aim of the present study is to evaluate the protective impact of cardioprotective medications on the chemotherapy- induced cardiotoxicity.
Eligibility criteria
Qualifiers
Willingness of the legal representative of research participant to participate in the study by giving "informed consent."
Ability to take oral medication.
Age 2-18 years at the time of diagnosis.
Disqualifiers
Documented allergy to cardioprotective medications
Trial design
Treatments tested in this trial
- ACE Inhibitors
- β -Blockers
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov